Just the FACTs Home
FACT
    • Submit
      an Article
    • Past
      Newsletters
    • Article
      Index

In This Issue

  • Just the FACTs 2022 Volume 2
  • DUE JUNE 30, 2022: Standards Coordinating Body Seeks Comments on Chain of Identity Identifier Definitions and Requirements
  • FACT Announces Return to In-person Inspections October 1, 2022
  • FACT Seeks Candidates for Leadership Positions to Support New Growth Initiatives
  • FACT Provides Input to Donor Registry and Regulatory Agency
  • Congratulations to Robert Preti for Receiving the Prestigious ISCT Career Achievement Award
  • Cytotherapy Article Reviews Progress of ISBT 128 Labeling, Provides Example of Successful Standardization in Cellular Therapy
  • Examples of Label Reconciliation Methods to Prevent Mix-Ups of Cellular Therapy Products
  • FACT Events Returned to In-Person Format in April and May 2022!
  • Register for the Virtual FACT-ISCT Quality Boot Camp!
  • Upcoming Cord Blood Banking Educational Events to be in Person at Cord Blood Connect!
  • Quality Management Series 11: Corrective Action Plans
  • IEC Webinar Series: Solid Tumors
  • Want to stay up-to-date with what is going on at FACT? Follow our LinkedIn Page and Twitter Account for the latest updates!

Accreditation Statistics

Last updated November 2, 2026

Cellular Therapy Entities

  • Accredited: 303
  • Applicants: 45

Cord Blood Banks

  • Accredited: 50
  • Applicants: 4

A complete list of accredited organizations can be found at https://accredited.factglobal.org/.

2026 Initial Accreditations

  • American Red Cross Puerto Rico Region | San Juan, Puerto Rico
    • Collection by Apheresis (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • City of Hope Atlanta | Newnan, GA
    • Adult Autologous HPC Transplantation; Immune Effector Cellular Therapy; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • Grupo GSH | São Paulo, Brazil
    • Marrow Collection for Administration; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • Hoag Family Cancer Institute | Newport Beach, CA
    • Immune Effector Cellular Therapy; Apheresis for Further Manufacturing
  • Hospital Auxilio Mutuo Bone Marrow Transplant and Cellular Immunotherapy Program | San Juan, Puerto Rico
    • Adult Allogeneic & Autologous HPC Transplantation; Immune Effector Cellular Therapy; Marrow Collection; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • KK Women's and Children's Hospital – BMTCT Programme | Singapore
    • Pediatric Allogeneic & Autologous HPC Transplantation; Immune Effector Cellular Therapy; Marrow Collection; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • The MetroHealth System | Cleveland, OH
    • Adult Allogeneic & Autologous HPC Transplantation; Immune Effector Cellular Therapy; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • OhioHealth Blood and Marrow Transplant Program | Columbus, OH
    • Adult Allogeneic & Autologous HPC Transplantation; Immune Effector Cellular Therapy; Marrow Collection; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • Ramaiah Memorial Hospital | Bengaluru, Karnataka, India
    • Adult & Pediatric Allogeneic & Autologous HPC Transplantation; Apheresis Collection for Administration; Processing with Minimal Manipulation
  • Royal North Shore Hospital Bone Marrow Transplant and Cellular Therapies Program | St Leonards, NSW, Australia
    • Adult Allogeneic & Autologous HPC Transplantation; Immune Effector Cellular Therapy; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • King Hussein Cancer Center | Amman, Jordan
    • Adult and Pediatric Allogeneic and Autologous Hematopoietic Progenitor Cell Transplantation, Immune Effector Cellular Therapy, Marrow Cellular Therapy Product Collection for Administration, Cellular Therapy Product Collection by Apheresis (Administration & Further Manufacturing); Cellular Therapy Product Processing with Minimal and More Than Minimal Manipulation
  • CHRISTUS Children’s Blood and Marrow Transplant Center | San Antonio, Texas
    • Pediatric Allogeneic and Autologous Hematopoietic Progenitor Cell Transplantation, Marrow Cellular Therapy Product Collection for Administration, Cellular Therapy Product Collection by Apheresis for Administration, and Cellular Therapy Product Processing with Minimal Manipulation
  • Brown University Health Cancer Institute | Providence, RI
    • Adult Autologous HPC Transplantation; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal and More than Minimal Manipulation
  • LifeSouth Community Blood Centers, Inc. | Gainesville, FL
    • Processing with Minimal Manipulation
  • Chang Gung Memorial Hospital | Taoyuan City, Taiwain
    • Adult and Pediatric Allogeneic & Autologous HPC Transplantation; Immune Effector Cellular Therapy; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal and More than Minimal Manipulation
  • Nationwide Children's Hospital, Abigail Wexner Research Institute, Biologics Manufacturing Resource | Columbus, OH
    • Processing with More than Minimal Manipulation
  • Tennessee Oncology | Nashville, TN
    • Immune Effector Cellular Therapy; Apheresis Collection for Further Manufacturing
  • Hospital Sírio-Libanês | São Paulo, São Paulo, Brazil
    • Adult Allogeneic & Autologous HPC Transplantation; Immune Effector Cellular Therapy; Marrow Collection for Further Administration; Apheresis Collection (Administration & Further Manufacturing); Processing with Minimal Manipulation
  • Saskatchewan Cancer Agency Stem Cell Transplant and Cellular Therapy Program | Saskatchewan, Saskatoon, Canada
    • Adult allogeneic and autologous hematopoietic progenitor cell transplantation; Immune effector cellular therapy; Marrow cellular therapy product collection for administration; Cellular therapy product collection by apheresis for administration and further manufacturing ; Cellular therapy product processing with minimal manipulation
  • University of Missouri Ellis Fischel Cancer Center | Columbia, MO
    • Adult autologous hematopoietic progenitor cell transplantation; Immune effector cellular therapy; Cellular therapy product collection by apheresis for administration and further manufacturing; Cellular therapy product processing with minimal manipulation
  • Clovis Community Medical Center | Clovis, CA
    • Immune effector cellular therapy; Cellular therapy product collection by apheresis for further manufacturing

Want to stay up-to-date with what is going on at FACT? Follow our LinkedIn Page and Twitter Account for the latest updates!

Posted in :: 2022 Volume 2 :: Friday, June 17th, 2022

 

 

 

 

 

 

 

 

 

 

 


« Previous Article
Home
Next Article »

Services

  • Standards
  • Accreditation Process
  • Education and Resources
  • Become an Inspector
  • FACT Accreditation Portal
  • FACT Consulting

Company

  • Store
  • Accredited Organizations
  • Leadership
  • About

Help and Advice

  • FAQ
  • FACT Staff
  • Portal Resource Center

Search:

  

Phone:

402-920-7001

Address:

6901 Dodge St. Suite 201
Omaha, NE 68132

fact@factglobal.org

FACT

Promoting quality patient care and laboratory practice in cellular therapies

Principal
Members:  

ASTCT Logo
ISCT Logo

© 2026  The Foundation for the Accreditation of Cellular Therapy. All Rights Reserved.